DA Davidson lowered shares of Imperva (NASDAQ:IMPV) from a buy rating to a neutral rating in a research report released on Friday, July 27th, MarketBeat Ratings reports. DA Davidson currently has $46.00 price target on the software maker’s stock, down from their previous price target of $56.00.
Other analysts also recently issued reports about the company. BidaskClub upgraded Imperva from a hold rating to a buy rating in a research note on Tuesday, April 17th. ValuEngine upgraded Imperva from a sell rating to a hold rating in a research note on Saturday, June 2nd. Stephens increased their target price on Imperva from $61.00 to $67.00 and gave the company an overweight rating in a research note on Thursday, June 14th. BTIG Research reiterated a hold rating on shares of Imperva in a research note on Sunday, April 29th. Finally, Oppenheimer increased their target price on Imperva from $55.00 to $60.00 and gave the company an outperform rating in a research note on Monday, June 18th. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of $54.00.
Imperva traded up $0.05, reaching $45.95, on Friday, MarketBeat Ratings reports. 490,839 shares of the company traded hands, compared to its average volume of 421,130. Imperva has a one year low of $37.17 and a one year high of $57.65.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IMPV. Legal & General Group Plc raised its holdings in Imperva by 27.9% during the second quarter. Legal & General Group Plc now owns 519,725 shares of the software maker’s stock valued at $25,077,000 after acquiring an additional 113,280 shares during the period. Oppenheimer & Co. Inc. bought a new stake in Imperva during the second quarter valued at about $222,000. BlackRock Inc. raised its holdings in Imperva by 4.0% during the second quarter. BlackRock Inc. now owns 2,362,641 shares of the software maker’s stock valued at $113,997,000 after acquiring an additional 91,444 shares during the period. Thompson Siegel & Walmsley LLC bought a new stake in Imperva during the second quarter valued at about $11,917,000. Finally, GSA Capital Partners LLP raised its holdings in Imperva by 80.2% during the second quarter. GSA Capital Partners LLP now owns 24,348 shares of the software maker’s stock valued at $1,175,000 after acquiring an additional 10,837 shares during the period.
Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.
See Also: Book Value Per Share in Stock Trading
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.